Top 10 Patient Safety Concerns in 2019
The ECRI Institute identified these issues as the biggest patient safety concerns in 2019. Can medtech help tackle them?
IVD
Could CRISPR Diagnostics Provide a Valuable Weapon in the Fight against Pandemic Flu?
The new diagnostic assay format could provide a means of performing low-cost tests for particular strains of flu at the point of care, but there are challenges to address.
A New Task Force Promises to Cut Through Emergency Diagnostics Clutter
Product launches, study results, and approvals were signs of a pretty significant week in diagnostics, as FDA, CMS, and CDC formed a task force to make diagnostics rapidly available during public health emergencies.
Abbott Offers up Rapid Influenza Diagnostic
Influenza and its complications cause as many as 140,000 to 710,000 hospitalizations and 12,000 to 56,000 deaths annually in the U.S.
A Blood Test for Pain?
Indiana University of Medicine researchers said the test can help identify biomarkers in the blood and could actually help in the fight against opioid abuse.
New Assay Gives Greater Insight on HIV
The research behind the development of the test was supported by the National Institute of Allergy and Infectious Diseases, part of NIH.
A New Collaboration Could Be Key in the Early Detection of Lung Cancer
Biodesix and MRM are the latest diagnostic firms to enter into a partnership geared at the early detection of lung cancer.
C2N Launches Trial for Alzheimer’s Detection Test
In addition, the company said it has received a breakthrough device designation for the test, which predicts amyloid PET scan results in patients.
Using Sequencing and AI for Infectious Disease Detection
Day Zero Diagnostics has raised $8.6 million to further develop a sequencing-based rapid diagnostic that identifies, within hours, both the species and the antibiotic resistance profile of a bacterial pathogen.
23andMe Looking at Hereditary Colorectal Cancer Syndrome
The Mountain View, CA-based company received a nod from FDA for the MUTYH-Associated Polyposis Genetic Health Risk report.
New Blood Test Determines Likelihood of Lung Transplant Rejection
The donor-derived cell-free DNA test was developed by the National Institutes of Health/National Heart Blood and Lung Institute.
A Newly Developed Nanosensor Quickly Detects Disease
The test, developed by Researchers at the Institute for Global Food Security at Queen’s University Belfast, can detect proteases, enzyme markers that are responsible for the progression of many diseases.
New Data Boosts Value Proposition of AlloSure
The first donor-derived cell-free DNA test to assess allograft health in kidney transplant patients is also beneficial for repeat transplant recipients, a new study finds.
Antibiotic-Resistance-Screening Diagnostic Wins CE Mark
The new test could help clinicians quickly determine the appropriate treatment for patients.
ArcherDx Seeking Broader Reach for Cancer Diagnostic
The Boulder, CO-based company has been granted a Breakthrough Device Designation for its liquid biopsy and tissue specimen assay.
Noninvasive Test for Colon Cancer Screening Offered as an Alternative to Colonoscopy for Screening
CellMax Life has developed a blood test that it says can identify precancerous adenomas with similar accuracy as colonoscopy, which may facilitate better compliance with screenings and increase detection rates.